Non-tumescent, non-thermal treatment of varicose veins

ClariVein is a fully-disposable, minimally invasive device used to treat patients with stages 2 – 6 of venous disease. Using a technology often referred to as MOCA (mechanical occlusion chemically assisted), the system consists of a specialty infusion catheter with a rotating wire tip designed for the controlled 360-degree dispersion of physician-specified agents to the targeted treatment area. Therefore, ClariVein provides no risk of thermal nerve damage.
ClariVein is intended to be used with vascular imaging, usually ultrasound. The procedure can be easily performed in an office setting and administering local anaesthesia. Patients often return to their normal activities immediately post-operative.



  • Non-tumescent
  • Non-thermal
  • Clinically proven
  • 74% less post-operative pain and less bruising¹
  • Reduced recovery time to 1 day¹
  • Reduced procedure time¹

NICE Guidelines

Mechanochemical ablation as a treatment procedure has been listed as a proven safe treatment for the closure of varicose veins. This approval is the result of collective information gathered from patients treated previously under auditable measures.

Mechanochemical ablation (ClariVein) in comparison to other treatment options scores very well in  certain areas such as reduced pain both during the procedure, and post procedure. Closure rates are excellent and of course with ClariVein there is no use of tumescent anaesthesia and the procedure is non-thermal; these factors greatly improve recovery time and comfort for the patient who enjoy a virtually pain-free, fast procedure.²


For further information about ClariVein or to arrange a visit by one of our product specialists, please contact us here.


Reference Material


1. R. van Eekeren, et al., Postoperative Pain and Early Quality of Life after Radiofrequency Ablation and Mechanochemical Endovenous Ablation of Incompetent Great Saphenous Veins, Journal of Vascular Surgery, Volume 57, Number 2, February 2013, p. 445-450.

2. NICE Guidelines